Tenenbaum Fabian 4
4 · Bellerophon Therapeutics, Inc. · Filed Jan 4, 2019
Insider Transaction Report
Form 4
Tenenbaum Fabian
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2019-01-02+12,500→ 3,688,697 totalExercise: $0.88Exp: 2029-01-02→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]1. This option was granted on January 2, 2019. This option vests in quarterly installments over a four-years period from the date of grant.